CD8A and neoplasm: In vitro and in vivo studies performed by Dranoff et al. in 2002 showed a long-lasting immune response of CD4+ and CD8+ T cells, NKT-cells and antibodies after vaccination with GM-CSF secreting irradiated tumor cells [93].